Table 3:
1 mg/kg (n=4) | 3 mg/kg (n=13) | 10 mg/kg (n=15) | 20 mg/kg (n=21) | |
---|---|---|---|---|
Any treatment-related adverse event | 3 (75%) | 9 (69%) | 14 (93%) | 17 (21%) |
Grade ≥3 treatment-related adverse event | 1 (25%) | 0 | 5 (33%) | 3 (14%) |
Treatment-related adverse event leading to treatment discontinuation | 1 (25%) | 0 | 1 (7%) | 4 (19%) |
Serious treatment-related adverse event | 0 | 0 | 3 (20%) | 3 (14%) |
Immune-related treatment-related adverse event | 0 | 1 (8%) | 2 (13%) | 2 (10%) |
Data are n (%).